170 related articles for article (PubMed ID: 28523449)
1. Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia.
Kárai B; Hevessy Z; Szánthó E; Csáthy L; Ujfalusi A; Gyurina K; Szegedi I; Kappelmayer J; Kiss C
Pathol Oncol Res; 2018 Apr; 24(2):345-352. PubMed ID: 28523449
[TBL] [Abstract][Full Text] [Related]
2. Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.
Kárai B; Gyurina K; Ujfalusi A; Sędek Ł; Barna G; Jáksó P; Svec P; Szánthó E; Nagy AC; Müller J; Simon R; Vojczek Á; Szegedi I; Tiszlavicz LG; Kowalczyk JR; Kolenova A; Kovács GT; Szczepański T; Dworzak M; Schumich A; Attarbaschi A; Nebral K; Haas OA; Kappelmayer J; Hevessy Z; Kiss C
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823516
[TBL] [Abstract][Full Text] [Related]
3. Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures.
Gyurina K; Kárai B; Ujfalusi A; Hevessy Z; Barna G; Jáksó P; Pálfi-Mészáros G; Póliska S; Scholtz B; Kappelmayer J; Zahuczky G; Kiss C
Front Oncol; 2019; 9():1063. PubMed ID: 31709175
[No Abstract] [Full Text] [Related]
4. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Kiss F; Hevessy Z; Veszprémi A; Katona E; Kiss C; Vereb G; Muszbek L; Kappelmayer JN
Thromb Haemost; 2006 Aug; 96(2):176-82. PubMed ID: 16894461
[TBL] [Abstract][Full Text] [Related]
5. Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Simon Á; Bagoly Z; Hevessy Z; Csáthy L; Katona É; Vereb G; Ujfalusi A; Szerafin L; Muszbek L; Kappelmayer J
Cytometry B Clin Cytom; 2012 Jul; 82(4):209-16. PubMed ID: 22434605
[TBL] [Abstract][Full Text] [Related]
6. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
Kiss F; Simon A; Csáthy L; Hevessy Z; Katona E; Kiss C; Kappelmayer J
Cytometry A; 2008 Mar; 73(3):194-201. PubMed ID: 18000871
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
8. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
[TBL] [Abstract][Full Text] [Related]
10. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
[TBL] [Abstract][Full Text] [Related]
12. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype.
Demina I; Zerkalenkova E; Illarionova O; Olshanskaya Y; Verzhbitskaya T; Semchenkova A; Tsaur G; Rusanova E; Belogurova M; Baidun L; Plyasunova S; Konyuhova T; Kazakova A; Fechina L; Novichkova G; Samochatova E; Myakova N; Maschan A; Popov AM
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2803-2811. PubMed ID: 31463716
[TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
17. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
Kucher N; Schroeder V; Kohler HP
Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612
[TBL] [Abstract][Full Text] [Related]
18. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.
Wu S; Gessner R; von Stackelberg A; Kirchner R; Henze G; Seeger K
Cancer; 2005 Mar; 103(5):1054-63. PubMed ID: 15651075
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
20. CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.
Newton JG; Horan JT; Newman S; Rossi MR; Ketterling RP; Park SI
Pediatr Dev Pathol; 2017 Jun; 20(3):224-231. PubMed ID: 28521628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
